Literature DB >> 22548903

Platelet uptake of GABA and glutamate in patients with bipolar disorder.

Simona Daniele1, Eleonora Da Pozzo, Marianna Abelli, Anna Panighini, Stefano Pini, Camilla Gesi, Lisa Lari, Alessandra Cardini, Giovanni Battista Cassano, Claudia Martini.   

Abstract

OBJECTIVES: Gamma aminobutyric acid (GABA) and glutamate (Glu) are the major neurotransmitters of the human central nervous system, and their actions are determined by specific transporters. Several studies suggest that GABA- and Glu-uptake mechanisms are modified in patients with bipolar disorder (BD). We explored the functionality of the GABA and Glu transporters in three groups of patients with BD, each with a different polarity of index episode (manic, depressive, or euthymic) at the time of blood draw.
METHODS: Forty patients with a diagnosis of BD, according to DSM-IV-TR criteria, and 15 healthy subjects were enrolled in the study. GABA and Glu uptake were evaluated in freshly prepared platelets using [(3) H]GABA or [(3) H]glutamate.
RESULTS: Compared to controls, GABA uptake was significantly increased in patients with depressive episodes and significantly decreased in subjects with manic episodes. Glu uptake was significantly increased in patients with index manic episodes and in euthymic patients compared to healthy controls. Moreover, a positive correlation was found between GABA platelet uptake and Hamilton Depression Rating Scale scores and between Glu platelet uptake and Young Mania Rating Scale scores in patients with manic episodes.
CONCLUSIONS: We found a relationship between GABA- and Glu-uptake levels and the polarity of episodes in patients with BD. Our data suggest that the functionality of both GABA and Glu transporters could represent a useful neurobiological marker to characterize the real polarity of an index episode of illness in patients with BD.
© 2012 John Wiley and Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548903     DOI: 10.1111/j.1399-5618.2012.01005.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  4 in total

1.  Plasma metabolomic profiles associated with chronic distress in women.

Authors:  Katherine H Shutta; Raji Balasubramanian; Tianyi Huang; Shaili C Jha; Oana A Zeleznik; Candyce H Kroenke; Lesley F Tinker; Jordan W Smoller; Ramon Casanova; Shelley S Tworoger; JoAnn E Manson; Clary B Clish; Kathryn M Rexrode; Susan E Hankinson; Laura D Kubzansky
Journal:  Psychoneuroendocrinology       Date:  2021-09-20       Impact factor: 4.693

Review 2.  An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

3.  The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Rahim Badrfam; Seyed-Ali Mostafavi; Ali Khaleghi; Shahin Akhondzadeh; Atefeh Zandifar; Malihe Farid; Nami Mohammadian Khonsari; Mohammad Reza Mohammadi
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

Review 4.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.